Humanwell Healthcare Group Co Ltd (600079) - Total Liabilities

Latest as of June 2026: CN¥14.75 Billion CNY ≈ $2.16 Billion USD

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has total liabilities worth CN¥14.75 Billion CNY (≈ $2.16 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of Humanwell Healthcare Group Co Ltd to see how much of total assets are deployed in long-term investments.

Humanwell Healthcare Group Co Ltd - Total Liabilities Trend (1994–2025)

This chart illustrates how Humanwell Healthcare Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Humanwell Healthcare Group Co Ltd asset portfolio.

Humanwell Healthcare Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
AVIC Capital Co Ltd
SHG:600705
China CN¥376.59 Billion
Jinneng Holding Shanxi Coal Industry Co Ltd
SHG:601001
China CN¥7.96 Billion
Acerinox
MC:ACX
Spain €3.97 Billion
IONOS GROUP N
XETRA:IOS
Germany €1.30 Billion
Ningxia Orient Tantalum Industry Co Ltd
SHE:000962
China CN¥814.10 Million
Poonawalla Fincorp Limited
NSE:POONAWALLA
India Rs499.23 Billion
UMICORE S.A UNSP.ADR 1/4
F:NVJ
Germany €7.19 Billion
Cia de Distribucion Integral
MC:LOG
Spain €7.66 Billion

Liability Composition Analysis (1994–2025)

This chart breaks down Humanwell Healthcare Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Humanwell Healthcare Group Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.94 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.76 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.40 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Humanwell Healthcare Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Humanwell Healthcare Group Co Ltd (1994–2025)

The table below shows the annual total liabilities of Humanwell Healthcare Group Co Ltd from 1994 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥14.74 Billion
≈ $2.16 Billion
-6.81%
2024-12-31 CN¥15.82 Billion
≈ $2.31 Billion
-1.80%
2023-12-31 CN¥16.11 Billion
≈ $2.36 Billion
-10.92%
2022-12-31 CN¥18.08 Billion
≈ $2.65 Billion
-8.47%
2021-12-31 CN¥19.75 Billion
≈ $2.89 Billion
+1.64%
2020-12-31 CN¥19.44 Billion
≈ $2.84 Billion
-10.94%
2019-12-31 CN¥21.82 Billion
≈ $3.19 Billion
+0.57%
2018-12-31 CN¥21.70 Billion
≈ $3.18 Billion
+11.71%
2017-12-31 CN¥19.43 Billion
≈ $2.84 Billion
+34.48%
2016-12-31 CN¥14.45 Billion
≈ $2.11 Billion
+61.04%
2015-12-31 CN¥8.97 Billion
≈ $1.31 Billion
+39.30%
2014-12-31 CN¥6.44 Billion
≈ $942.28 Million
+39.18%
2013-12-31 CN¥4.63 Billion
≈ $677.03 Million
+9.85%
2012-12-31 CN¥4.21 Billion
≈ $616.30 Million
+38.93%
2011-12-31 CN¥3.03 Billion
≈ $443.59 Million
+59.49%
2010-12-31 CN¥1.90 Billion
≈ $278.12 Million
+54.87%
2009-12-31 CN¥1.23 Billion
≈ $179.58 Million
-6.61%
2008-12-31 CN¥1.31 Billion
≈ $192.30 Million
+5.13%
2007-12-31 CN¥1.25 Billion
≈ $182.91 Million
+4.88%
2006-12-31 CN¥1.19 Billion
≈ $174.40 Million
-6.60%
2005-12-31 CN¥1.28 Billion
≈ $186.72 Million
+15.97%
2004-12-31 CN¥1.10 Billion
≈ $161.00 Million
+9.51%
2003-12-31 CN¥1.00 Billion
≈ $147.02 Million
+34.99%
2002-12-31 CN¥744.27 Million
≈ $108.91 Million
+25.15%
2001-12-31 CN¥594.72 Million
≈ $87.03 Million
+208.11%
2000-12-31 CN¥193.03 Million
≈ $28.25 Million
+6.85%
1999-12-31 CN¥180.65 Million
≈ $26.44 Million
+14.21%
1998-12-31 CN¥158.17 Million
≈ $23.15 Million
+76.93%
1997-12-31 CN¥89.40 Million
≈ $13.08 Million
+3.52%
1996-12-31 CN¥86.36 Million
≈ $12.64 Million
+55.32%
1995-12-31 CN¥55.60 Million
≈ $8.14 Million
+11.27%
1994-12-31 CN¥49.97 Million
≈ $7.31 Million
--

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.47 Billion
CN¥30.57 Billion CNY
Market Cap Rank
#3861 Global
#559 in China
Share Price
CN¥18.73
Change (1 day)
-0.27%
52-Week Range
CN¥16.37 - CN¥21.54
All Time High
CN¥37.30
About

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more